131-I mIBG
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 131-I mIBG, covering 2025-10-22 to 2025-10-22. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Study of 131-I mIBG Followed by Nivolumab & Dinutuximab Beta Antibodies in Children With Relapsed/Refractory Neuroblastoma [Phase 1]